HTD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Corcept Therapeutics Inc

Watchlist Manager

Watchlist

Price: 67.16 EUR

Market Cap: €4.5B

C	Corcept Therapeutics Inc XBER:HTD	US
	Avalo Therapeutics Inc F:C6K0	US
C	Credit Agricole SA XMUN:XCA	FR
	Meituan F:9MDA	CN
D	Diageo PLC PAR:DGE	UK
D	Deutsche Boerse AG DUS:DB1	DE
D	Dalipal Holdings Ltd HKEX:1921	CN
U	United Utilities Group PLC XMUN:UUEC	UK
B	British American Tobacco PLC XHAM:BMT	UK
	Credit Agricole SA PAR:ACA	FR

Profitability Summary

Corcept Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

99% > 98%

Low Operating Margin

Sustainable 3Y Average Operating Margin

15%

Declining Operating Margin

23% > 1%

Low Net Margin

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

22% > 7%

Exceptional Free Cash Flow Margin

13%

Strong 3Y Average Free Cash Flow Margin

23%

Declining Free Cash Flow Margin

31% > 13%

Low ROE

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

31%

Declining ROIC

63% > 3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.